Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-02-01 @ 2:10 PM
Study NCT ID:
NCT01183468
Status:
TERMINATED
Last Update Posted:
2018-06-13
First Post:
2010-08-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Research Trial of Aralast in New Onset Diabetes (RETAIN)
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetes Mellitus, Type 1 | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Diabetes Mellitus, Type 1 (new-onset) | View |
| None | Diabetes Mellitus, Insulin-Dependent (new-onset) | View |
| None | new-onset T1DM | View |
| None | new-onset T1D | View |
| None | Diabetes Mellitus, Juvenile-Onset | View |
| None | Diabetes, Autoimmune | View |
| None | Aralast NP | View |
| None | Alpha-1 Antitrypsin | View |
| None | AAT | View |